Veracyte in the news
March 7, 2023
Veracyte Sees Revenue Growth in Oncology Classifiers, New Genomic Products, Global Expansion
LabPulse
March 2, 2023
How Single-Cancer Testing Could Revolutionize Diagnostics
Clinical Lab Products Magazine
February 23, 2023
Veracyte Ramps up Clinical Evidence Generation, Driving Gains in Prostate and Thyroid Test Business
GenomeWeb
December 16, 2022
Veracyte Announces Clinical Practice Data for Thyroid Cancer Classifier
LabPulse
October 21, 2022
Envisia Test May Help Identify ILD Patients with Progressing Disease
Pulmonary Fibrosis News
September 22, 2022
Veracyte Deciphers the Conundrum of Aggressive Prostate Cancer in African American Men
BioWorld
June 14, 2021
With New Data, Veracyte Aims to Expand Prostate Cancer Test Reach Following Decipher Acquisition
FierceBiotech